Clinical Trial Update: Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action [Phase 3]

View source ↗

Summary

A Phase 3 trial in adolescents and adults 12 years and older with seasonal allergic rhinitis to assess onset of action has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Not disclosed

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 3 | Status: COMPLETED